For research use only. Not for therapeutic Use.
Eprobemide (CAT: I019691) is a non-competitive reversible inhibitor of monoamine oxidase A (MAO-A). It acts by binding to and inhibiting the activity of MAO-A, an enzyme responsible for the breakdown of neurotransmitters like serotonin, dopamine, and norepinephrine. This pharmacologic action leads to increased levels of these neurotransmitters in the brain, contributing to improved mood and alleviation of depressive symptoms. Eprobemide finds application in the field of pharmaceuticals, specifically as an antidepressant agent targeting the central nervous system and addressing mood disorders.
| Catalog Number | I019691 |
| CAS Number | 87940-60-1 |
| Molecular Formula | C₁₄H₁₉ClN₂O₂ |
| Purity | ≥95% |
| Target | Monoamine Oxidase |
| Reference | [1]. Gol’dina OA, et al. The action of befol and its derivatives on monoamine oxidase of different origins. Biull Eksp Biol Med. 1991 Mar;111(3):279-80.<br>[2]. Donskaya, et al. Antidepressant Befol Synthesized Via Interaction of 4-Chloro-N-(3-chloropropyl)benzamide with Morpholine. Pharmaceutical Chemistry Journal, 2004 Jun; 38(7): 381-384. |
